Mauricio Concha

ORCID: 0000-0001-9920-3681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Acute Ischemic Stroke Management
  • HIV-related health complications and treatments
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Atrial Fibrillation Management and Outcomes
  • Neurosurgical Procedures and Complications
  • Venous Thromboembolism Diagnosis and Management
  • Cerebral Palsy and Movement Disorders
  • HIV/AIDS Research and Interventions
  • T-cell and Retrovirus Studies
  • Cerebrovascular and Carotid Artery Diseases
  • Animal Disease Management and Epidemiology
  • Thermal Regulation in Medicine
  • Intracranial Aneurysms: Treatment and Complications
  • Foot and Ankle Surgery
  • Cardiac Arrest and Resuscitation
  • Cardiac Arrhythmias and Treatments
  • Vector-Borne Animal Diseases
  • Botulinum Toxin and Related Neurological Disorders
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Infectious Encephalopathies and Encephalitis
  • Stroke Rehabilitation and Recovery
  • Lower Extremity Biomechanics and Pathologies

Sarasota Memorial Hospital
2005-2024

University of Cincinnati Medical Center
2024

University of Virginia
2024

Arcadia
2024

Centre Hospitalier Universitaire de Clermont-Ferrand
2023

Stanford University
2020

University of Cincinnati
2020

Phoenix Children's Hospital
2020

Massachusetts General Hospital
2020

Mayo Clinic in Florida
2020

John R. Sims Jennifer A. Zimmer Cynthia Evans Ming‐Chi Lu Paul Ardayfio and 95 more JonDavid Sparks Alette M. Wessels Sergey Shcherbinin Hong Wang Emel Serap Monkul Nery Emily C. Collins Paul R. Solomon Stephen Salloway Liana G. Apostolova Oskar Hansson Craig Ritchie Dawn A. Brooks Mark A. Mintun Daniel Skovronsky Rafael Abreu Pinky Agarwal Puja Aggarwal Marc Agronin Alison Allen Dario Altamirano Gustavo Alva James Andersen Allan Anderson Donald D. Anderson Jennifer Arnold Takashi Asada Yasuhiro Aso Vikram Atit Ricardo Ayala Michael Badruddoja Hanna Badzio-jagiello Michal Bajaček Dávid Barton David G. Bear Sabrina Benjamin Richard Bergeron Perminder Bhatia Sandra E. Black Allan Block Mohammad Reza Bolouri Wendy Bond Jean Bouthillier Sharon A. Brangman Bruce Brew Sarah Brisbin Toby Brisken Amy Brodtmann Mark Brody Jared R. Brosch Celia Brown Paul Brownstone Sylwia Bukowczan Jeffrey M. Burns A Cabrera Horace Capote Ángel Carrasco Jose Cevallos Yepez Eric Chavez Howard Chertkow Urszula Chyrchel-Paszkiewicz Anthony Ciabarra Edward Clemmons Daniel M. Cohen Robert M. Cohen Ian J. Cohen Mauricio Concha Brian Costell Denis Crimmins Yvette Cruz-pagan Adolfo Cueli Robert Cupelo Maciej Czarnecki David Darby P. L. J. Dautzenberg Peter Paul De Deyn Jose De La Gandara Kenneth Deck David DiBenedetto Mark DiBuono Eric Dinnerstein Ahmet Dirican Shanker Dixit Jacek Dobryniewski Ryan Drake Peter Drysdale Ranjan Duara John P. Duffy Aaron Ellenbogen Victor Faradji Marc Feinberg Robert Feldman Simon Fishman Stephen Flitman Concetta Forchetti Ivonne Fraga

Importance There are limited efficacious treatments for Alzheimer disease. Objective To assess efficacy and adverse events of donanemab, an antibody designed to clear brain amyloid plaque. Design, Setting, Participants Multicenter (277 medical research centers/hospitals in 8 countries), randomized, double-blind, placebo-controlled, 18-month phase 3 trial that enrolled 1736 participants with early symptomatic disease (mild cognitive impairment/mild dementia) low/medium or high tau pathology...

10.1001/jama.2023.13239 article EN JAMA 2023-07-17

Andexanet alfa is a modified recombinant inactive form of human factor Xa developed for reversal inhibitors.We evaluated 352 patients who had acute major bleeding within 18 hours after administration inhibitor. The received bolus andexanet, followed by 2-hour infusion. coprimary outcomes were the percent change in anti-factor activity andexanet treatment and percentage with excellent or good hemostatic efficacy at 12 end infusion, adjudicated on basis prespecified criteria. Efficacy was...

10.1056/nejmoa1814051 article EN New England Journal of Medicine 2019-02-07

We determined incidence and future projections of dementia after AIDS onset in 492 homosexual men with the Baltimore/Los Angeles sites Multicenter Cohort Study, 64 whom developed dementia. studied various risk factors for dementia, including demographic clinical features, medical history, markers immune status before AIDS, zidovudine use. During first 2 years HIV at an annual rate 7%. Overall, 15% cohort followed through death The median survival was 6.0 months. Using a proportional hazards...

10.1212/wnl.43.11.2245 article EN Neurology 1993-11-01
Truman J. Milling Saskia Middeldorp Lizhen Xu Bruce Koch Andrew M. Demchuk and 95 more John W. Eikelboom Peter Verhamme Alexander T. Cohen Jan Beyer‐Westendorf C. Michael Gibson José López‐Sendón Mark Crowther Ashkan Shoamanesh Michiel Coppens Jeannot Schmidt Pierre Albaladejo Stuart J. Connolly Ravinder Anand Aveh Bastani Carol L. Clark Mauricio Concha John A. Cornell Keith Dombrowski Gregory J. Fermann James Fulmer Joshua N. Goldstein D.J. Kereiakes Truman J. Milling Daniel J. Pallin Neha Patel Majed A. Refaai M. Rehman Alvin H. Schmaier E. Schwarz William C. Shillinglaw Michael Spohn Tohru Takata Arvind Venkat James Welker Ian J. Welsby Joanna Y. Wilson L. Van Keer Franck Verschuren Mark Blostein John W. Eikelboom Katharina Althaus Jörg Berrouschot Gary Braun T. Doeppner Rainer Dziewas Sabine Genth‐Zotz P. Greinacher F. Hamann Frank Hanses W. Heide Bernd Kallmuenzer Pawel Kermer Sven Poli Georg Royl Sebastian Schellong Steffen Schnupp Jürgen Schwarze Claudia Spies Götz Thomalla Matthias von Mering Karin Weißenborn Frank A. Wollenweber Christoph Gumbinger Ulrich Jaschinski M. Maschke H-C. Mochmann Waltraud Pfeilschifter C. Pohlmann Ralf Zahn Pierre Bouzat Jeannot Schmidt Cristina Díez Vallejo Bernard Floccard Michiel Coppens Sanne van Wissen Eduardo Arellano‐Rodrigo Ermengol Vallés Raza Alikhan Kerry J. Breen Richard Hall Mark Crowther Pierre Albaladejo Alexander T. Cohen Andrew M. Demchuk Jeannot Schmidt D. George Wyse D.A. Garcia M.H. Prins Juliet Nakamya H.R. Büller K. W. Mahaffey John H. Alexander John A. Cairns R G Hart Cameron D. Joyner

Background: Andexanet alfa is a modified recombinant inactive factor Xa (FXa) designed to reverse FXa inhibitors. ANNEXA-4 (Andexanet Alfa, Novel Antidote the Anticoagulation Effects of Factor Inhibitors) was multicenter, prospective, phase-3b/4, single-group cohort study that evaluated andexanet in patients with acute major bleeding. The results final analyses are presented. Methods: Patients bleeding within 18 hours inhibitor administration were enrolled. Co-primary end points anti-FXa...

10.1161/circulationaha.121.057844 article EN cc-by-nc-nd Circulation 2023-02-20
Patrick D. Lyden Thomas Hemmen James C. Grotta Karen Rapp Karin Ernström and 95 more Teresa Rzesiewicz S. Parker Mauricio Concha Syed I. Hussain Sachin Agarwal Brett C. Meyer Julie Jurf Irfan Altafullah Rema Raman Mary Jane Hess Anthony Mullin Mary Jane Hess Gabriela Muranevici Bonnie Piantadosi Gustavo Jimenez‐Maggiora Jia‐Shing So Sonia Jain Michael N. Diringer Colin P. Derdeyn Barney J. Stern Scott Hamilton W. Dalton Dietrich Kyra J. Becker Midori A. Yenari Ulrich Dirnagl Christine A.C. Wijman Ángel Chamorro Scott Janis Claudia S. Moy Felice Lin Shlee Song Konrad Schlick Pooja Khanolkar Nancy Edwards Ana Roldan Jeanette Wilson Amy S. Little Pam Lewis William Neil Nhu Bruce Amy Guzik Ajeet Sohdi Nabeel Herial Bruce Ovbiagele Dawn Meyer Royya Modir Ronelyn Chavez Ángela Velázquez Stephan A. Mayer Jan Claassen Cristina Falo Gilda Tafreshi William Neil Nhu Bruce Amy Guzik Royya Modir N. C. Kelly Ronelyn Chavez Bruce Ovbiagele Erin Shell Guy Dugan Elizabeth Kim A G Tanner Patrik Michel Ashraf Eskandari Mauro Oddo Tamarah Suys Suzette Rémillard Maria Cordier Robert Brown Sara Jasak Louise D. McCullough Robert T. Brautigam Andrei V. Alexandrov April Sisson Karen C. Albright Gregor Broessner Erich Schmutzhard Elissanet Escioglou William Jones Sharon N. Poisson Jennifer Simpson Qaisar Shah Karin Jonczak Patricia Bussinger Christopher Lewandowski Shannen Berry AnneMarie Lundell Joseph Miller Salvador Cruz‐Flores Eve Holzer Susan Torretta David M. Brown Laura Heim Carlos Smith

Therapeutic hypothermia is a potent neuroprotectant approved for cerebral protection after neonatal hypoxia-ischemia and cardiac arrest. acute ischemic stroke safe feasible in pilot trials. We designed study protocol to provide safer, faster therapeutic patients.Safety procedures 4°C saline infusions cooling were added the ICTuS trial (Intravascular Cooling Treatment of Stroke) protocol. A femoral venous intravascular catheter intravenous recombinant tissue-type plasminogen activator...

10.1161/strokeaha.116.014200 article EN Stroke 2016-11-14

<i>Background and Relevance:</i> Atherosclerotic stenosis of the major intracranial arteries is an important cause transient ischemic attack (TIA) or stroke. Of 900,000 patients who suffer a TIA stroke each year in USA, responsible for approximately 10%, i.e. 90,000 patients. There have been no prospective trials evaluating antithrombotic therapies preventing recurrent vascular events these The main objective this trial to compare warfarin [International Normalized Ratio (INR)...

10.1159/000068744 article EN Neuroepidemiology 2003-01-01

10.1016/s0140-6736(19)31192-4 article EN The Lancet 2019-05-24
Maged D Fam Hussein A. Zeineddine Javed Khader Eliyas Agnieszka Stadnik Michael Jesselson and 95 more Nichol McBee Karen Lane Ying Cao Meijing Wu Lingjiao Zhang Richard E. Thompson Sayona John Wendy Ziai Daniel F. Hanley Issam A. Awad Harold P. Adams Opeolu Adeoye Sachin Agarwal Maria I. Aguilar E. François Aldrich Safdar Ansari David Antezana Agnieszka Ardelt Fuat Arikán Pál Barzó Péter Bazsó Julian Bösel M. Boulton Diederik Bulters Kenneth Butcher Paul J. Camarata Jean-Louis Caron Kevin M. Cockroft Mauricio Concha H. Mark Crabtree Salvador Cruz‐Flores László Csiba David A. Decker Alberto Torres Díaz Benjamin Emanuel William D. Freeman Michael T. Froehler Latorre Julius Gen Martin Gizzi Nicole R. Gonzales R. Scott Graham David M. Greer Christiana E. Hall Sagi Harnof Mark R. Harrigan Ann Helms Alan Hoffer James Holsapple Hagen B. Huttner Michael Jacoby Jack Jallo Michael Luke James Eric Jüttler Marcelo Kern Thomas Kerz Inam Kureshi Christos Lazaridis Didier Ledoux Jody Leonardo Alexandre Luiz Longo George Α. Lopez Darren Lovick Andreas R. Luft Jorge Marconde de Souza Nevo Margalit Mason Markowski Joan Martí–Fàbregas Sheila Cristina Ouriques Martins A. D. Mendelow Dominik Michalski Thomas Mirsen Asma Moheet David R. Newell George Newman Christopher S. Ogilvy Hiren C. Patel Pedro Telles Cougo Pinto Sven Poli Michael Reinert Guy Rosenthal Fernando Santiago Michael Schneck David B. Seder Qaisar Shah Kavian Shahi Gisele Sampaio Silva David Sinclair László Szapáry Ashis Tayal Fernando D. Testai Michel T. Torbey Kristi Tucker Stanley Tuhrim Igor Ugorec Panayiotis N. Varelas

<h3>Objective:</h3> To investigate the temporal pattern and relevant associations of CSF inflammatory measures after intraventricular hemorrhage (IVH). <h3>Methods:</h3> We analyzed prospectively collected cell counts protein glucose levels from participants in Clot Lysis Evaluation Accelerated Resolution IVH phase III (CLEAR III) trial. Corrected leukocyte count index were calculated to adjust for leukocytes attributable circulating blood. Data chronologically plotted. (daily, mean, median,...

10.1212/wnl.0000000000004493 article EN Neurology 2017-09-09

Twenty-three children who had unilateral surgery for idiopathic clubfeet underwent gait analysis and isokinetic muscle-strength testing at an average of 10 years after surgical release. Ankle sagittal-plane kinematics were disturbed in 20 clubfeet. Fifteen internal foot-progression angle. Genu valgum knee hyperextension common. Plantarflexion power was decreased by 23% on the side (p = 0.00005). Quadriceps weakness (defined as a decrease strength >10% nonoperated-on limb's strength) seen...

10.1097/00004694-199711000-00018 article EN Journal of Pediatric Orthopaedics 1997-11-01

A definitive relation between HIV-1 load and the clinical diagnosis of HIV-1-associated dementia (HAD) has not yet been established. Knowledge neuroanatomic distribution in brain individuals with HAD encephalitis may facilitate elucidation this relation. Nine AIDS were analyzed postmortem by three independent methods each assessment performed blinded to others: 1) a neuropsychiatric review records for evidence possible HAD, 2) DNA determination quantitative polymerase chain reaction (PCR)...

10.1097/00042560-199711010-00002 article EN Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1997-11-01

To determine the frequency and characteristics of microembolic signals (MES) in subarachnoid hemorrhage (SAH).Twenty-three patients with aneurysmal SAH were monitored transcranial Doppler ultrasonography for presence MES vasospasm. Each middle cerebral artery was 30 minutes three times each week. Patients excluded if they had traumatic or cardiac arterial sources emboli. Monitoring initiated 6.3 days (1-16 d) after lasted 6.6 (1-13 d). Eleven individuals without other cerebrovascular...

10.1097/00006123-200205000-00016 article EN other-oa Neurosurgery 2002-05-01

A high-incidence focus of tropical spastic paraparesis (TSP) occurs on the South Pacific coast Colombia. Of 55 patients studied, 52 (94.5%) had IgG antibodies to human T-cell lymphotropic virus type I (HTLV-I) in serum and/or cerebrospinal fluid. Control groups did not show similar high positivity. Our results suggest that HTLV-I or other antigenically related retroviruses may be cause TSP Similar clinical, laboratory, and epidemiological findings have been reported widely remote...

10.1002/ana.410230730 article EN Annals of Neurology 1988-01-01

Angular gyrus (Gerstmann) syndrome is classically described as finger agnosia, right-left disorientation, agraphia and acalculia in association to lesions the left angular gyrus. Aphasia not typically part of this syndrome. Here we report a 58 year old right-handed male, with an ischemic lesion gyrus, who developed sudden loss speech expression comprehension, slowly recovered over following few weeks. After several months he showed significant improvement on his language skills understanding...

10.1080/026870300410964 article EN Aphasiology 2000-07-01

Summary: In young adults, a major neurologic complication of HIV-1 infection is cognitive motor impairment. Epidemiologic findings suggest that increasing age significant risk factor for HIV-1-associated dementia as the AIDS-defining illness. Findings from few studies have directly measured cognition in younger and older HIV-1-infected however, been mixed, part, because small sample sizes other methodologic differences between studies. The authors present preliminary on functioning...

10.1097/00126334-200306012-00006 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2003-06-01

Background: The purpose of the study was to examine relationship between age and plasma viral load in HIV-1-infected individuals. Design: experimental method recruit older (> 50 years age) younger (18–39 measured using Roche Molecular Systems UltraSensitive HIV-1 Monitor test reflexively with standard Amplicor HIV quantify range 50–750 000 copies RNA/ml plasma. Subjects: A total 135 HIV-1-seropositive individuals (at Centers for Disease Control Prevention early symptomatic stage B or late...

10.1097/00002030-200401001-00013 article EN AIDS 2004-01-01

The clinical syndrome earlier designated as paraparesia espástica del Pacífico is an isolated form of tropical spastic paraparesis (TSP) that was reported in 1981 the southern Pacific lowlands Colombia and near Tumaco. features are similar to those TSP Jamaica, Martinique, Seychelles, Ivory Coast Africa resemble also human T-lymphotropic virus type I (HTLV-I)-associated myelopathy described Japan. Since HTLV-I infection closely associated with TSP, we conducted a case-control study evaluate...

10.1002/ana.410230736 article EN Annals of Neurology 1988-01-01

Twenty-three children who had unilateral surgery for idiopathic clubfeet underwent gait analysis and isokinetic muscle-strength testing at an average of 10 years after surgical release. Ankle sagittal-plane kinematics were disturbed in 20 clubfeet. Fifteen internal foot-progression angle. Genu valgum knee hyperextension common. Plantarflexion power was decreased by 23% on the side (p = 0.00005). Quadriceps weakness (defined as a decrease strength > 10% nonoperated-on limb's strength) seen...

10.1097/01241398-199711000-00018 article EN Journal of Pediatric Orthopaedics 1997-11-01

Abstract Human immunodeficiency virus type 1 (HIV‐1) p24 antigen, a putative marker of load, was assayed in 79 blood and 83 cerebrospinal fluid (CSF) samples from 90 HIV‐1–seropositive individuals with or without demetia. Twenty‐eight subjects had no evidence neuropsychological impairment, 17 mild impairment objective dementia, 45 were demented. HIV‐1 antigen detected more frequently CSF demented (19/40) than normal (1/26) mildly impaired (1/17) 67% significant dementia (MSK stages 2–4)....

10.1002/ana.410360109 article EN Annals of Neurology 1994-07-01

This study presents an analysis of the factors associated with HTLV-I seroprevalence in endemic area Tumaco, Colombia. During June to August 1988, 1,077 individuals were selected at random from a population 45,594. The overall prevalence rate antibodies was 2.8%. Among females significantly higher (p < 0.02) than among males. Rates increased substantially age. history use intravenous medications 0.001) those without such history. Logistic regression included age years, indicators for male...

10.1089/aid.1992.8.651 article EN AIDS Research and Human Retroviruses 1992-05-01
Coming Soon ...